Efficacy of Low Dose Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding
Status:
Active, not recruiting
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
We prepare this study to compare the efficacy of intermittent intravenous PPI infusion
(relatively low dose PPI therapy) than continous PPI infusion method. Our hypothesis is that
intermittent (40mg as a bolus injection daily for 72 hours) PPI therapy is not inferior to
conventional high dose therapy.